SCHEMBL29648339

SCHEMBL29648339

C=Cc1cc(S(=O)(=O)NC)cnc1Nc1ccc(C(F)(F)F)cn1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.53
▸ TNNI3K Q59H18 4/20 0.53
▸ KMT2A Q03164 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ BRAF P15056 2/20 0.39
▸ GAA P10253 4/20 0.39
▸ TDP1 Q9NUW8 1/20 0.37
▸ TEAD1 P28347 1/20 0.36
▸ YAP1 P46937 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ MAPK10 P53779 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34
▸ EGFR P00533 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24497432 1.00 MAPT (0.53) MAPTTNNI3KKMT2AMEN1KDM4E
SCHEMBL24497321 0.87 TNNI3K (0.50) MAPTTNNI3KKMT2AMEN1BRAF
SCHEMBL29648442 0.85 TNNI3K (0.55) MAPTTNNI3KKMT2AMEN1KDM4E
SCHEMBL24497379 0.85 TNNI3K (0.55) MAPTTNNI3KKMT2AMEN1KDM4E
SCHEMBL24497376 0.77 MAPT (0.42) MAPTKMT2AMEN1KDM4EGAA
SCHEMBL29648360 0.77 MAPT (0.42) MAPTKMT2AMEN1KDM4EGAA
SCHEMBL24497429 0.75 MAPT (0.66) MAPTTNNI3KKMT2AMEN1KDM4E
SCHEMBL26669276 0.74 GAA (0.40) MAPTTNNI3KKMT2AMEN1KDM4E
SCHEMBL29648418 0.73 TEAD1 (0.61) MAPTTNNI3KKMT2AMEN1KDM4E
SCHEMBL24497430 0.73 TEAD1 (0.61) MAPTTNNI3KKMT2AMEN1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4281073-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2023-11-29 — — EP disclosed
EP-4255895-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2023-10-11 — — EP disclosed
WO-2022159986-A1 COMBINATION OF A 3-(IMIDAZOL-4-YL)-4-(AMINO)-BENZENESULFONAMIDE TEAD INHIBITOR WITH AN EGFR INHIBITOR AND/OR MEK INHIBITOR FOR USE IN THE TREATMENT OF LUNG CANCER Ikena Oncology, Inc. (US) 2022-07-28 — — WO disclosed
WO-2022120354-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
Send feedback